PI Pharma Insight

Tyruko 300mg/15ml concentrate for inf vials

BNF presentation 0802040W0BCAAAA within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.

Product

Tyruko

Chemical substance

Natalizumab

Presentation code

0802040W0BCAAAA

Usage overview

Total items and spend derived from NHS dispensing data.

Items dispensed

No data available

NHS spend (£)

No data available

Recent activity

No data available

Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.

Dispensing trend

Month-by-month national usage.

Month Items dispensed
No data available.

Top pharmacies dispensing this medicine

Identify providers with the highest utilisation to focus engagement and support.

Pharmacy Items Region
No data available.